Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Net Cash Flow (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Net Cash Flow readings, the most recent being $374.0 million for Q4 2025.

  • Quarterly Net Cash Flow rose 444.33% to $374.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $363.3 million through Dec 2025, up 345.38% year-over-year, with the annual reading at $363.3 million for FY2025, 345.38% up from the prior year.
  • Net Cash Flow hit $374.0 million in Q4 2025 for Terns Pharmaceuticals, up from $4.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $374.0 million in Q4 2025 and bottomed at -$108.6 million in Q4 2024.
  • Average Net Cash Flow over 5 years is $22.5 million, with a median of $942500.0 recorded in 2021.
  • Peak annual rise in Net Cash Flow hit 5181.82% in 2021, while the deepest fall reached 493.0% in 2021.
  • Terns Pharmaceuticals' Net Cash Flow stood at -$17.1 million in 2021, then soared by 569.8% to $80.2 million in 2022, then tumbled by 47.92% to $41.8 million in 2023, then crashed by 360.01% to -$108.6 million in 2024, then skyrocketed by 444.33% to $374.0 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Net Cash Flow are $374.0 million (Q4 2025), $4.7 million (Q3 2025), and $6.9 million (Q2 2025).